ScientifyResearch logo
Grant Alerts

GRANT Guide

Home » Grants » Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) (worldwide)

Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) (worldwide)

The Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) funding from the National Institutes of Health seeks applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug-using behaviors (defined as alcohol, tobacco, prescription and other drugs) and related disorders, prevention of drug use and HIV, and health service utilization. Applications are open to researchers at research institutions in the USA and worldwide. Applications are also open to small businesses. Applicants may apply for up to 275,000 USD direct costs for up to 2 years.

Opportunity number: RFA-DA-24-037.

There are three assessment rounds per year, the next letters of intent are due on July 9, 2023 and full applications are due on August 9, 2023.

Intended for: Early-career principal investigators|Mid-career researchers|Senior researchers|Small business & industry

Discipline: Neurology

Challenge: Clinical Trials

Sign in with your free account to see important eligibility criteria, including research location, citizenship, legal working rights and deadline/s.

Sign-in for link to funder’s page
Create Grant Alerts

…share with your friends

Related Posts

Search all grants
Logo2

more time for research

About
Us

Funding
Blog & Events

Special
Research Funding

Funding by
Career Stage

Funding by
Subject

Funding by
Location

COPYRIGHT © 2023 SCIENTIFYRESEARCH
Logo2

more time for research

COPYRIGHT © 2023 SCIENTIFYRESEARCH

Sign-up for the
scientifyRESEARCH
monthly research
funding newsletter

You can unsubscribe at any time.